Ajit Ramalingam - 29 Apr 2022 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role: SVP, Chief Accounting Officer
Signature: /s/ Ajit Ramalingam
Issuer symbol: BIO
Transactions as of: 29 Apr 2022
Net transactions value: -$49,158
Form type: 4
Filing time: 02 May 2022, 14:42:52 UTC
Previous filing: 03 Sep 2021
Next filing: 08 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIO	Bio-Rad A Common Stock	Options Exercise	$0	+277	+66%	$0.000000	698	29 Apr 2022	Direct	F1, F2
transaction	BIO	Bio-Rad A Common Stock	Tax liability	$49,158	-96	-14%	$512.06	602	29 Apr 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIO	Restricted Stock Units	Options Exercise	$0	-277	-25%	$0.000000	831	29 Apr 2022	Bio-Rad A Common Stock	277	$0.000000	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares of Class A common stock acquired on the vesting of restricted stock units.
F2	Includes 12.1142, 5.1601, and 13.0147 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2021, 12/31/2021, and 03/31/2022, respectively.
F3	Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4	On April 29, 2020, the reporting person was granted 1,384 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.